S)-N-(5-((R)-2--피라졸로[1,5-A]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드의 제조 방법
페닐(5-((R)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-3,3a-디히드로피라졸로 [1,5-a]피리미딘-3-일)카르바메이트 또는 유사한 유도체(화학식 13)를 (S)-피롤리딘-3-올(화학식 14)과 반응시키는 것에 의한, (S)-N-(5-((R)-2-(2,5-디플루오로페닐) 피롤리딘-1-일)피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드 (화학식 I) 또는 그의 염의 제조 방법. (R)-5-(2-(2,5-디플루오로페닐) 피롤리딘-1-일) -3-니트로피라졸로[1,5-a]피리미딘(화학식 11)의 (R)-5...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Korean |
Published |
12.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 페닐(5-((R)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-3,3a-디히드로피라졸로 [1,5-a]피리미딘-3-일)카르바메이트 또는 유사한 유도체(화학식 13)를 (S)-피롤리딘-3-올(화학식 14)과 반응시키는 것에 의한, (S)-N-(5-((R)-2-(2,5-디플루오로페닐) 피롤리딘-1-일)피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드 (화학식 I) 또는 그의 염의 제조 방법. (R)-5-(2-(2,5-디플루오로페닐) 피롤리딘-1-일) -3-니트로피라졸로[1,5-a]피리미딘(화학식 11)의 (R)-5-(2-(2,5-디플루오로페닐) 피롤리딘-1-일)피라졸로[1,5-a]피리미딘-3-아민(화학식 12)으로의 환원에 의한, 페닐(5-((R)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-3,3a-디히드로피라졸로[1,5-a] 피리미딘-3-일)카르바메이트(화학식 13) 또는 유사한 유도체의 제조 방법. (R)-N-((R)-1-(2,5-디플루오로페닐)-3-(1,3-디옥산-2-일)프로필)-2-메틸프로판-2-술핀아미드 (화학식 19)를 산 및 환원제로 처리하는 것에 의한, (R)-2-(2,5-디플루오로페닐) 피롤리딘(R)-2-히드록시숙시네이트 (화학식 10)의 제조 방법. (S)-N-(5-((R)-2-(2,5-디플루오로페닐)-피롤리딘-1-일)-피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드는, 예를 들어 암 치료를 위한 티로신 키나제(TRK) 억제제이다.
Process for preparing (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a] pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide (formula I) or a salt thereof by reacting phenyl(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3,3a-dihydropyrazolo[1,5-a]pyrimidin-3-yl)carbamate or a similar derivative (formula 13) with (S)-pyrrolidin-3-ol (formula 14).Process for preparing phenyl(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3,3a-dihydropyrazolo[1,5-a]pyrimidin-3-yl)carbamate (formula 13) or a similar derivative by reduction of (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine (formula 11) to (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (formula 12).Process for preparing (R)-2-(2,5-difluorophenyl)pyrrolidine(R)-2-hydroxysuccinate (formula 10) by treating (R)-N-((R)-1-(2,5-difluorophenyl)-3-(1,3-dioxan-2-yl)propyl)-2-methylpropane-2-sulfinamide (formula 19) with an acid and a reducing agent.(S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-l-yl)-pyrazolo[l,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, is a tyrosin kinase (TRK) inhibitor for trearing e.g. cancer. |
---|---|
AbstractList | 페닐(5-((R)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-3,3a-디히드로피라졸로 [1,5-a]피리미딘-3-일)카르바메이트 또는 유사한 유도체(화학식 13)를 (S)-피롤리딘-3-올(화학식 14)과 반응시키는 것에 의한, (S)-N-(5-((R)-2-(2,5-디플루오로페닐) 피롤리딘-1-일)피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드 (화학식 I) 또는 그의 염의 제조 방법. (R)-5-(2-(2,5-디플루오로페닐) 피롤리딘-1-일) -3-니트로피라졸로[1,5-a]피리미딘(화학식 11)의 (R)-5-(2-(2,5-디플루오로페닐) 피롤리딘-1-일)피라졸로[1,5-a]피리미딘-3-아민(화학식 12)으로의 환원에 의한, 페닐(5-((R)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-3,3a-디히드로피라졸로[1,5-a] 피리미딘-3-일)카르바메이트(화학식 13) 또는 유사한 유도체의 제조 방법. (R)-N-((R)-1-(2,5-디플루오로페닐)-3-(1,3-디옥산-2-일)프로필)-2-메틸프로판-2-술핀아미드 (화학식 19)를 산 및 환원제로 처리하는 것에 의한, (R)-2-(2,5-디플루오로페닐) 피롤리딘(R)-2-히드록시숙시네이트 (화학식 10)의 제조 방법. (S)-N-(5-((R)-2-(2,5-디플루오로페닐)-피롤리딘-1-일)-피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드는, 예를 들어 암 치료를 위한 티로신 키나제(TRK) 억제제이다.
Process for preparing (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a] pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide (formula I) or a salt thereof by reacting phenyl(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3,3a-dihydropyrazolo[1,5-a]pyrimidin-3-yl)carbamate or a similar derivative (formula 13) with (S)-pyrrolidin-3-ol (formula 14).Process for preparing phenyl(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3,3a-dihydropyrazolo[1,5-a]pyrimidin-3-yl)carbamate (formula 13) or a similar derivative by reduction of (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine (formula 11) to (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (formula 12).Process for preparing (R)-2-(2,5-difluorophenyl)pyrrolidine(R)-2-hydroxysuccinate (formula 10) by treating (R)-N-((R)-1-(2,5-difluorophenyl)-3-(1,3-dioxan-2-yl)propyl)-2-methylpropane-2-sulfinamide (formula 19) with an acid and a reducing agent.(S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-l-yl)-pyrazolo[l,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, is a tyrosin kinase (TRK) inhibitor for trearing e.g. cancer. |
Author | SPENCER STACEY ANDREWS STEVEN W HACHE BRUNO JIANG YUTONG HAAS JULIA REYNOLDS MARK JUENGST DERRICK EARY CHARLES TODD |
Author_xml | – fullname: JIANG YUTONG – fullname: ANDREWS STEVEN W – fullname: REYNOLDS MARK – fullname: EARY CHARLES TODD – fullname: HACHE BRUNO – fullname: JUENGST DERRICK – fullname: HAAS JULIA – fullname: SPENCER STACEY |
BookMark | eNrjYmDJy89L5WQoD9bU9dPVMNXV0AjS1DXS1X07Zc_ruXveLNzxeuGcaEMdU13HWJDQsjWv1-94PWWGrrHum7l7NIHU23kdryfPeb1w7pvuOSAVC5eAFAFVGOq-2bnl9dItrzdvfdME1jZ5zpu5MxTeLJjzZuEGhdcbVr7eNJWHgTUtMac4lRdKczMou7mGOHvophbkx6cWFyQmp-allsR7BxkZGFoaGBhbmpibOBoTpwoAjHdgsA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | KR20190039474A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20190039474A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:00:05 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20190039474A3 |
Notes | Application Number: KR20187036701 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190412&DB=EPODOC&CC=KR&NR=20190039474A |
ParticipantIDs | epo_espacenet_KR20190039474A |
PublicationCentury | 2000 |
PublicationDate | 20190412 |
PublicationDateYYYYMMDD | 2019-04-12 |
PublicationDate_xml | – month: 04 year: 2019 text: 20190412 day: 12 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | ARRAY BIOPHARMA, INC LOXO ONCOLOGY, INC EARY CHARLES TODD |
RelatedCompanies_xml | – name: EARY CHARLES TODD – name: LOXO ONCOLOGY, INC – name: ARRAY BIOPHARMA, INC |
Score | 3.1707215 |
Snippet | 페닐(5-((R)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-3,3a-디히드로피라졸로 [1,5-a]피리미딘-3-일)카르바메이트 또는 유사한 유도체(화학식 13)를 (S)-피롤리딘-3-올(화학식 14)과 반응시키는 것에 의한, (S)-N-(5-((R)-2-(2,5-디플루오로페닐)... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | S)-N-(5-((R)-2--피라졸로[1,5-A]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드의 제조 방법 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190412&DB=EPODOC&locale=&CC=KR&NR=20190039474A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsQQmjFQT8zRdYEFoAuygJAGzlDnoDo1kc5M0S0Njc5MU0Dikr5-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o6BtZuJoZGai5Ota4C_i7-zmrOzrXeQml8QRM7A2NLE3MSRmYEV1JAGnbTvGuYE2pdSgFypuAkysAUAzcsrEWJgys4XZuB0ht29JszA4Qud8gYyobmvWIShPFhT109Xw1RXQyNIU9dIV_ftlD2v5-55s3DH64Vzog11THUdY0FCy9a8Xr_j9ZQZusa6b-bu0QRSb-d1vJ485_XCuW-654BULFwCUgRUYaj7ZueW10u3vN689U0TWNvkOW_mzlB4s2DOm4UbFF5vWPl601RRBmU31xBnD12gD-LhARbvHYTsXWMxBpa8_LxUCQaFZAuLtBTTNCOjZEvQVHCSpampRXISME4SDY2MUiwNJRlk8JkkhV9amoELxNUFn4Qow8BSUlSaKgusskuS5MAhDQCeBLNn |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsQQmjFQT8zRdYEFoAuygJAGzlDnoDo1kc5M0S0Njc5MU0Dikr5-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o6BtZuJoZGai5Ota4C_i7-zmrOzrXeQml8QRM7A2NLE3MSRmYHVHHQ-L6jxFOYE2pdSgFypuAkysAUAzcsrEWJgys4XZuB0ht29JszA4Qud8gYyobmvWIShPFhT109Xw1RXQyNIU9dIV_ftlD2v5-55s3DH64Vzog11THUdY0FCy9a8Xr_j9ZQZusa6b-bu0QRSb-d1vJ485_XCuW-654BULFwCUgRUYaj7ZueW10u3vN689U0TWNvkOW_mzlB4s2DOm4UbFF5vWPl601RRBmU31xBnD12gD-LhARbvHYTsXWMxBpa8_LxUCQaFZAuLtBTTNCOjZEvQVHCSpampRXISME4SDY2MUiwNJRlk8JkkhV9anoHTI8TXJ97H089bmoELJKULPhVRhoGlpKg0VRZYfZckyYFDHQAsjrZU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=S%29-N-%285-%28%28R%29-2--%ED%94%BC%EB%9D%BC%EC%A1%B8%EB%A1%9C%5B1%2C5-A%5D%ED%94%BC%EB%A6%AC%EB%AF%B8%EB%94%98-3-%EC%9D%BC%29-3-%ED%9E%88%EB%93%9C%EB%A1%9D%EC%8B%9C%ED%94%BC%EB%A1%A4%EB%A6%AC%EB%94%98-1-%EC%B9%B4%EB%A5%B4%EB%B3%B5%EC%82%AC%EB%AF%B8%EB%93%9C%EC%9D%98+%EC%A0%9C%EC%A1%B0+%EB%B0%A9%EB%B2%95&rft.inventor=JIANG+YUTONG&rft.inventor=ANDREWS+STEVEN+W&rft.inventor=REYNOLDS+MARK&rft.inventor=EARY+CHARLES+TODD&rft.inventor=HACHE+BRUNO&rft.inventor=JUENGST+DERRICK&rft.inventor=HAAS+JULIA&rft.inventor=SPENCER+STACEY&rft.date=2019-04-12&rft.externalDBID=A&rft.externalDocID=KR20190039474A |